Skip to main content
رجوع
BMXMF logo

bioMérieux S.A.

جودة البيانات: 100%
ذروة بيع
BMXMF
OTC Healthcare Medical - Diagnostics & Research
KWD 102.25
KWD 0.00 (0.00%)
القيمة السوقية: 12.06B
مُدرج أيضًا باسم BMXXY OTC
نطاق اليوم
KWD 102.25 KWD 115.00
نطاق 52 أسبوعًا
KWD 102.25 KWD 152.00
حجم التداول
868
متوسط 50 يوم / 200 يوم
KWD 117.87 / KWD 130.64
الإغلاق السابق
KWD 102.25

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 30.4 0.2
P/B 2.9 3.0
ROE % 9.6 3.6
Net Margin % 9.8 3.8
Rev Growth 5Y % 4.8 9.9
D/E 0.1 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 7.17
KWD 7.01 – KWD 7.49
5.37B 1
FY2029 KWD 6.61
KWD 6.46 – KWD 6.90
5.09B 1
FY2028 KWD 6.02
KWD 5.89 – KWD 6.29
4.79B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-27 KWD 2.50 KWD 2.33 -6.8%
2025-06-30 KWD 2.55 KWD 1.59 -37.6%
2024-12-31 KWD 2.23 KWD 1.89 -15.2%
2024-06-29 N/A KWD 1.95
2023-12-30 N/A KWD 1.81
2023-06-30 N/A KWD 1.49
2022-12-31 N/A KWD 2.04
2022-06-30 N/A KWD 2.01

Dividend History

7 yr streak

Yield

0.01%

Payout Ratio

0.27%

Growth (3Y)

4.17%

Growth (5Y)

36.53%

Ex-Date Payment Date Amount Yield
Jun 09, 2026 Jun 11, 2026 KWD 1.14 1.11%
Jun 10, 2025 Jun 11, 2025 KWD 1.03 0.72%
Jun 10, 2024 Jun 11, 2024 KWD 0.91 0.89%
Jun 06, 2023 Jun 08, 2023 KWD 0.91 0.90%
Jun 06, 2022 Jun 08, 2022 KWD 0.91 0.89%
Jun 04, 2021 Jun 08, 2021 KWD 0.75 0.67%
Jul 14, 2020 Jul 16, 2020 KWD 0.22 0.15%
Jun 04, 2019 Jun 06, 2019 KWD 0.39 0.49%
Jun 05, 2018 Jun 07, 2018 KWD 0.40 0.44%
Jun 06, 2017 Jun 08, 2017 KWD 1.13 0.52%
Jun 07, 2016 Jun 09, 2016 KWD 1.13 0.86%
Jun 05, 2015 Jun 09, 2015 KWD 1.11 0.96%
Jun 03, 2014 Jun 06, 2014 KWD 1.36 1.20%
Jun 04, 2013 Jun 07, 2013 KWD 1.28 1.32%
Jun 01, 2012 Jun 06, 2012 KWD 1.22 1.49%
Jun 17, 2011 Jun 22, 2011 KWD 1.40 1.32%
Jun 14, 2010 Jun 17, 2010 KWD 1.13 1.17%
Jun 15, 2009 Jun 18, 2009 KWD 1.12 1.15%
Jun 16, 2008 Jun 19, 2008 KWD 1.18 1.43%

النقاط الرئيسية

Revenue grew 4.77% annually over 5 years — modest growth
Debt/Equity of 0.11 — conservative balance sheet
Generating 452.83M in free cash flow
P/E of 30.36 — premium valuation
Cash machine — converts 113.96% of earnings into free cash flow
Capital efficient — spends only 8.24% of revenue on capex

النمو

Revenue Growth (5Y)
4.77%
Revenue (1Y)2.22%
Earnings (1Y)-8.06%
FCF Growth (3Y)105.62%

الجودة

Return on Equity
9.57%
ROIC9.22%
Net Margin9.77%
Op. Margin13.79%

الأمان

Debt / Equity
0.11
Current Ratio2.39
Interest Coverage0.00

التقييم

P/E Ratio
30.36
Forward P/E21.60
P/B Ratio2.94
EV/EBITDA21.31
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.22% Revenue Growth (3Y) 5.22%
Earnings Growth (1Y) -8.06% Earnings Growth (3Y) 5.41%
Revenue Growth (5Y) 4.77% Earnings Growth (5Y) -9.83%
Profitability
Revenue (TTM) 4.07B Net Income (TTM) 397.35M
ROE 9.57% ROA 7.13%
Gross Margin 52.63% Operating Margin 13.79%
Net Margin 9.77% Free Cash Flow (TTM) 452.83M
ROIC 9.22% FCF Growth (3Y) 105.62%
Safety
Debt / Equity 0.11 Current Ratio 2.39
Interest Coverage 0.00
Dividends
Dividend Yield 0.01% Payout Ratio 0.27%
Dividend Growth (3Y) 4.17% Dividend Growth (5Y) 36.53%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 30.36 Forward P/E 21.60
P/B Ratio 2.94 P/S Ratio 2.97
PEG Ratio -3.99 Forward PEG N/A
EV/EBITDA 21.31 Fwd EV/EBITDA 11.53
Forward P/S 2.88 Fwd Earnings Yield 4.63%
FCF Yield 3.75%
Market Cap 12.06B Enterprise Value 11.96B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.07B 3.98B 3.67B 3.59B 3.38B
Net Income 397.35M 432.20M 357.60M 452.40M 601.10M
EPS (Diluted) 3.34 3.64 3.01 3.82 5.06
Gross Profit 2.14B 2.22B 2.06B 2.01B 2.00B
Operating Income 560.99M 588.80M 439.00M 587.20M 784.30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.57B 5.77B 5.26B 5.19B 4.62B
Total Liabilities 1.47B 1.56B 1.51B 1.54B 1.44B
Shareholders' Equity 4.10B 4.20B 3.75B 3.60B 3.12B
Total Debt 461.23M 490.70M 518.80M 505.40M 462.50M
Cash & Equivalents 569.59M 449.80M 352.40M 552.60M 803.50M
Current Assets 2.54B 2.50B 2.21B 2.22B 2.21B
Current Liabilities 1.06B 1.13B 1.09B 1.13B 955.90M